Amgen Inc.
AMGN
$277.29
-$5.35-1.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.03B | 31.14B | 29.54B | 28.18B | 26.91B |
| Total Other Revenue | 1.40B | 1.39B | 1.39B | 1.35B | 1.28B |
| Total Revenue | 33.42B | 32.53B | 30.93B | 29.53B | 28.19B |
| Cost of Revenue | 10.46B | 12.20B | 10.70B | 9.28B | 7.80B |
| Gross Profit | 22.97B | 20.33B | 20.24B | 20.26B | 20.40B |
| SG&A Expenses | 7.10B | 7.01B | 6.73B | 6.24B | 5.69B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 230.00M | -613.00M | 114.00M | 221.00M | 118.00M |
| Total Operating Expenses | 23.75B | 24.37B | 22.95B | 20.81B | 18.39B |
| Operating Income | 9.68B | 8.17B | 7.99B | 8.73B | 9.80B |
| Income Before Tax | 4.61B | 4.68B | 3.53B | 4.35B | 7.86B |
| Income Tax Expenses | 519.00M | 449.00M | 395.00M | 582.00M | 1.14B |
| Earnings from Continuing Operations | 4.09K | 4.23K | 3.13K | 3.76K | 6.72K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.09B | 4.23B | 3.13B | 3.76B | 6.72B |
| EBIT | 9.68B | 8.17B | 7.99B | 8.73B | 9.80B |
| EBITDA | 15.16B | 13.60B | 12.92B | 13.16B | 13.73B |
| EPS Basic | 7.62 | 7.88 | 5.85 | 7.03 | 12.57 |
| Normalized Basic EPS | 7.69 | 5.55 | 5.82 | 6.22 | 7.82 |
| EPS Diluted | 7.55 | 7.81 | 5.81 | 7.00 | 12.49 |
| Normalized Diluted EPS | 7.62 | 5.50 | 5.78 | 6.18 | 7.76 |
| Average Basic Shares Outstanding | 2.15B | 2.15B | 2.14B | 2.14B | 2.14B |
| Average Diluted Shares Outstanding | 2.16B | 2.16B | 2.16B | 2.15B | 2.15B |
| Dividend Per Share | 9.00 | 8.88 | 8.76 | 8.64 | 8.52 |
| Payout Ratio | 118.14% | 112.70% | 150.06% | 122.96% | 67.83% |